ZNF415 and sarcopenia: Additionally, in patients with sarcopenia, MT1X and ARHGAP36 were upregulated, whereas FAM171A1, GPCPD1, ZNF415 and RXRG, were downregulated, demonstrating high diagnostic accuracy for sarcopenia and potential as predictive markers for screening [82].